Protagonist Therapeutics Inc (PTGX) stock is up 282.83% over the last 12 months, and the average rating from Wall Street analysts is a Strong Buy. InvestorsObserver’s proprietary ranking system, gives PTGX stock a score of 71 out of a possible 100.
That rank is primarily influenced by a long-term technical score of 86. PTGX's rank also includes a short-term technical score of 77. The fundamental score for PTGX is 49. In addition to the average rating from Wall Street analysts, PTGX stock has a mean target price of 36.6. This means analysts expect the stock to gain 19.80% over the next 12 months.
What's Happening with PTGX Stock Today
Protagonist Therapeutics Inc (PTGX) stock is up 4.09% while the S&P 500 is down -0.35% as of 9:46 AM on Wednesday, Mar 3. PTGX is up $1.20 from the previous closing price of $29.35 on volume of 40,877 shares. Over the past year the S&P 500 has gained 28.41% while PTGX is up 282.83%. PTGX lost -$2.16 per share in the over the last 12 months.
Click Here to get the full Stock Score Report on Protagonist Therapeutics Inc (PTGX) Stock.
